These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Smallpox vaccine: the reality, the risk. Taccetta-Chapnick M. RN; 2003 Jul; 66(7):52-8; quiz 60. PubMed ID: 12900999 [No Abstract] [Full Text] [Related]
3. Counselling of workers handling vaccinia virus. Williams NR, Cooper BM. Occup Med (Lond); 1993 Aug; 43(3):125-7. PubMed ID: 8400205 [Abstract] [Full Text] [Related]
4. Risks associated with vaccinia virus in the laboratory. MacNeil A, Reynolds MG, Damon IK. Virology; 2009 Mar 01; 385(1):1-4. PubMed ID: 19118854 [Abstract] [Full Text] [Related]
5. An analysis of how infection-control research applies to the dental-laboratory environment. Sabatini BM. Trends Tech Contemp Dent Lab; 1995 Jun 01; 12(5):26-8. PubMed ID: 9587265 [No Abstract] [Full Text] [Related]
6. Durability of vaccinia immunization based on reaction at the rechallenge site. Sauri M, Sibley C, Monk B, Nichols M, Lai S. Md Med; 2002 Jun 01; 3(2):44-51. PubMed ID: 12056228 [Abstract] [Full Text] [Related]
7. Laboratory-acquired vaccinia infection. Loeb M, Zando I, Orvidas MC, Bialachowski A, Groves D, Mahoney J. Can Commun Dis Rep; 2003 Aug 01; 29(15):134-6. PubMed ID: 12916394 [No Abstract] [Full Text] [Related]
8. AIDS risks and precautions for laboratory personnel. Carlson DA. MLO Med Lab Obs; 1988 Jan 01; 20(1):51-6. PubMed ID: 10314260 [No Abstract] [Full Text] [Related]
9. Body substance isolation: a comprehensive method for infection control. Luebbert PP. MLO Med Lab Obs; 1990 Apr 01; 22(4):35-8, 40. PubMed ID: 10128535 [Abstract] [Full Text] [Related]
10. Smallpox vaccination for investigators. Danner K. Lancet; 1989 Dec 02; 2(8675):1337-8. PubMed ID: 2574286 [No Abstract] [Full Text] [Related]
11. Does smallpox linger as risk to hospital personnel? Hosp Infect Control; 1978 Oct 02; 5(10):153-6. PubMed ID: 10313858 [No Abstract] [Full Text] [Related]
12. [Immunologic prophylaxis and the health professions]. Boccia A, Ricciardi G, Graziano G. Nuovi Ann Ig Microbiol; 1988 Oct 02; 39(4-5):379-95. PubMed ID: 3254491 [No Abstract] [Full Text] [Related]
14. Fighting the TB dragon. Brown JW. MLO Med Lab Obs; 1994 Feb 02; 26(2):31-2, 34, 36. PubMed ID: 10131764 [Abstract] [Full Text] [Related]
15. Recent recommendations from the Centers for Disease Control. Carpenter KL. Dent Today; 1991 Sep 02; 10(7):29. PubMed ID: 1667475 [No Abstract] [Full Text] [Related]
16. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1986 Aug 29; 35(34):540-2, 547-9. PubMed ID: 3018469 [No Abstract] [Full Text] [Related]
17. Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Apr 18; 57(15):401-4. PubMed ID: 18418346 [Abstract] [Full Text] [Related]
18. NIOSH recommendations for occupational health standards. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1983 Oct 07; 32 Suppl 1():3S-24S. PubMed ID: 6314113 [No Abstract] [Full Text] [Related]
19. Royal Alexandra develops AIDS infection control protocol. Hnatko SI. Dimens Health Serv; 1985 Sep 07; 62(8):25-8. PubMed ID: 3000858 [No Abstract] [Full Text] [Related]
20. [Analysis on status and characteristics of laboratory-acquired vaccinia virus infections cases]. Wei Q, Lu XC, Wu GZ. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb 07; 27(1):73-5. PubMed ID: 23855138 [Abstract] [Full Text] [Related] Page: [Next] [New Search]